Mechanisms of nitrosamine-mediated neurodegeneration: Potential relevance to sporadic alzheimer's disease

Journal of Alzheimer's Disease

Volumn 17, Issue 4, 2009, Pages 817-825

  De La Monte, Suzanne M ^a,b   Tong, Ming ^a  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

Alzheimer's disease; Diabetes mellitus; Environmental toxin; Neurodegeneration; Nitrosamine

Indexed keywords

4 HYDROXYNONENAL; 8 HYDROXYDEOXYGUANOSINE; ADENOSINE TRIPHOSPHATE; AMYLOID PRECURSOR PROTEIN; CHOLINE ACETYLTRANSFERASE; DIETHYLNITROSAMINE; INSULIN; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN C; TAU PROTEIN; UBIQUITIN; 4-HYDROXY-2-NONENAL; 8-OXO-7-HYDRODEOXYGUANOSINE; ALDEHYDE; AMYLOID BETA PROTEIN; DEOXYGUANOSINE; STREPTOZOCIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DNA DAMAGE; ENERGY METABOLISM; IMMUNOREACTIVITY; MITOCHONDRION; NERVE CELL; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; ANIMAL; CELL CULTURE; CEREBELLUM CORTEX; CHEMICALLY INDUCED; COMPLICATION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; LONG EVANS RAT; METABOLISM; NEWBORN;

ADENOSINE TRIPHOSPHATE; ALDEHYDES; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CEREBELLAR CORTEX; CHOLINE O-ACETYLTRANSFERASE; DEOXYGUANOSINE; DIETHYLNITROSAMINE; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY METABOLISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MITOCHONDRIA; NERVE DEGENERATION; NEURONS; OXIDATIVE STRESS; RATS; RATS, LONG-EVANS; RECEPTOR, IGF TYPE 2; STREPTOZOCIN; UBIQUITIN;

EID: 68949161708     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2009-1098     Document Type: Article

References (66)

1. Lijinsky W (1999) N-Nitroso compounds in the diet. Mutat Res 443, 129-138.
2. HotchkissJH(1989) Preformed N-nitroso compoundsin foods and beverages. Cancer Surv 8, 295-321.
3. Kearney PC (1980) Nitrosamines and pesticides: A special report on the occurrence of nitrosamines as terminal residues resulting from agricultural use of certain pesticides. Pure Appl Chem 52, 499-526.
4. Swann PF, Magee PN (1968) Nitrosamine-induced carcinogenesis. The alklylation of nucleic acids of the rat by N-methyl-N-nitrosourea, dimethylnitrosamine, dimethyl sulphate and methyl methanesulphonate. Biochem J 110, 39-47.
5. Pegg AE (1980) Metabolism of N-nitrosodimethylamine. IARC Sci Publ, 3-22.
6. Fournier P (1990) [Biotransformation of dimethylnitrosam-ine]. J Toxicol Clin Exp 10, 283-296.
7. Robbiano L, Mereto E, Corbu C, Brambilla G (1996) DNA damage induced by seven N-nitroso compounds in primary cultures of human and rat kidney cells. Mutat Res 368, 41-47.
8. Kyrtopoulos SA, Anderson LM, Chhabra SK, Souliotis VL, Pletsa V, Valavanis C, Georgiadis P (1997) DNA adducts and the mechanism ofcarcinogenesis and cytotoxicity of methylat-ing agents of environmental and clinical significance. Cancer Detect Prev 21, 391-405.
9. Otteneder M, Lutz WK (1999) Correlation of DNA adduct levels with tumor incidence: carcinogenic potency of DNA adducts. Mutat Res 424, 237-247.
10. Chuang CH, Hu ML(2006) Synergistic DNAdamage and lipid peroxidation in cultured human white blood cells exposed to 4-(methyl-nitrosamino)-1-(3-pyridyl) -1-butanone and ultraviolet A. Environ Mol Mutagen 47, 73-81.
11. Yadav AS, Bhatnagar D (2007) Chemo-preventive effect of Star anise in N-nitrosodiethylamine initiated and phenobarbi-tal promoted hepato- carcinogenesis. Chem Biol Interact 169, 207-214.
12. Espey MG, Miranda KM, Thomas DD, Xavier S, Citrin D, Vitek MP, Wink DA (2002) A chemical perspective on the interplay between NO, reactive oxygen species, and reactive nitrogen oxide species. Ann N Y Acad Sci 962, 195-206.
13. Lim IK (2003) Spectrum of molecular changes during hepato-carcinogenesis induced by DEN and other chemicals in Fisher 344 male rats [Mechanisms of Ageing and Development 123 (2002) 1665-1680]. Mech Ageing Dev 124, 697-708.
14. de la Monte SM, Wands JR (2008) Alzheimer's Disease is Type 3 Diabetes: Evidence Reviewed. J Diabetes Science Tech 2, 1101-1113.
15. de la Monte SM, Tong M, Lester-Coll N, Plater M, Jr., Wands JR (2006) Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease. J Alzheimers Dis 10, 89-109.
16. de la Monte SM, Wands JR (2005) Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J Alzheimers Dis 7, 45-61.
17. Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM (2006) Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease. J Alzheimers Dis 9, 13-33.
18. Frolich L, Blum-Degen D, Bernstein HG, Engelsberger S, Humrich J, Laufer S, Muschner D, Thalheimer A, Turk A, Hoyer S, Zochling R, Boissl KW, Jellinger K, Riederer P (1998) Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J Neural Transm 105, 423-438.
19. Grunblatt E, Koutsilieri E, Hoyer S, Riederer P (2006) Gene expression alterations in brain areas of intracerebroventricular streptozotocin treated rat. J Alzheimers Dis 9, 261-271.
20. Grunblatt E, Salkovic-Petrisic M, Osmanovic J, Riederer P, Hoyer S (2007) Brain insulin system dysfunction in strepto-zotocin intracerebroventricularly treated rats generates hyper-phosphorylated tau protein. J Neurochem 101, 757-770.
21. Hoyer S, Lee SK, Loffler T, Schliebs R (2000) Inhibition of the neuronal insulin receptor. An in vivo model for sporadic Alzheimer disease? Ann N Y Acad Sci 920, 256-258.
22. Salkovic-Petrisic M, Tribl F, Schmidt M, Hoyer S, Riederer P (2006) Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway. J Neurochem 96, 1005-1015.
23. Tahirovic I, Sofic E, Sapcanin A, Gavrankapetanovic I, Bach-Rojecky L, Salkovic-Petrisic M, Lackovic Z, Hoyer S, Riederer P (2007) Reduced brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus. Neurochem Res 32, 1709-1717.
24. Rossini AA, Like AA, Chick WL, Appel MC, Cahill GF, Jr. (1977) Studies of streptozotocin-induced insulitis and diabetes. Proc Natl Acad Sci U S A 74, 2485-2489.
25. Szkudelski T (2001) The mechanism of alloxan and strepto-zotocin action in B cells of the rat pancreas. Physiol Res 50, 537-546.
26. Bolzan AD, Bianchi MS (2002) Genotoxicity of streptozotocin. Mutat Res 512, 121-134.
27. Murata M, Takahashi A, Saito I, Kawanishi S (1999) Site-specific DNA methylation and apoptosis: induction by dia-betogenic streptozotocin. Biochem Pharmacol 57, 881-887.
28. Nukatsuka M, Sakurai H, Yoshimura Y, Nishida M, Kawada J (1988) Enhancement by streptozotocin of O2- radical generation by the xanthine oxidase system of pancreatic beta-cells. FEBS Lett 239, 295-298.
29. West IC (2000) Radicals and oxidative stress in diabetes. Diabet Med 17, 171-180.
30. Soscia SJ, Tong M, Xu XJ, Cohen AC, Chu J, Wands JR, de la Monte SM (2006) Chronic gestational exposure to ethanol causes insulin and IGF resistance and impairs acetylcholine homeostasis in the brain. Cell Mol Life Sci 63, 2039-2056.
31. Xu J, Yeon JE, Chang H, Tison G, Chen GJ, Wands JR, de la Monte SM(2003) Ethanol impairs insulin-stimulated neuronal survival in the developing brain: role of PTEN phosphatase. J Biol Chem 278, 26929-26937.
32. Chen GJ, Xu J, Lahousse SA, Caggiano NL, de la Monte SM (2003) Transient hypoxia causes Alzheimer-type molecular and biochemical abnormalities in cortical neurons: potential strategies for neuroprotection. J Alzheimers Dis 5, 209-228.
33. de la Monte SM, Neely TR, Cannon J, Wands JR (2001) Ethanol impairs insulin-stimulated mitochondrial function in cerebellar granule neurons. Cell Mol Life Sci 58, 1950-1960.
34. Baumber J, Ball BA, Gravance CG, Medina V, Davies-Morel MC (2000) The effect of reactive oxygen species on equine sperm motility, viability, acrosomal integrity, mitochondrial membrane potential, and membrane lipid peroxidation. J Androl 21, 895-902.
35. Chinopoulos C, Tretter L, Adam-Vizi V (1999) Depolarization of in situ mitochondria due to hydrogen peroxide-induced oxidative stress in nerve terminals: inhibition of alpha-ketoglutarate dehydrogenase. J Neurochem 73, 220-228.
36. Ramachandran V, Perez A, Chen J, Senthil D, Schenker S, Henderson GI (2001) In utero ethanol exposure causes mitochondrial dysfunction, which can result in apoptotic cell death in fetal brain: a potential role for 4- hydroxynonenal. Alcohol Clin Exp Res 25, 862-871.
37. de la Monte SM, Ganju N, Wands JR (1999) Microtiter im-munocytochemical ELISA assay: a novel and highly sensitive method of quantifying immunoreactivity. Biotechniques 26, 1073-1076.
38. Camandola S, Poli G, Mattson MP (2000) The lipid peroxidation product 4-hydroxy-2,3-nonenal increases AP-1- binding activity through caspase activation in neurons. J Neurochem 74, 159-168.
39. Picklo MJ, Amarnath V, McIntyre JO, Graham DG, Montine TJ (1999) 4-Hydroxy-2(E)-nonenal inhibits CNS mitochondrial respiration at multiple sites. J Neurochem 72, ̀4 1617-1624.
40. Angerer J, Ewers U, Wilhelm M (2007) Human biomonitor-ing: state of the art. Int J Hyg Environ Health 210, 201-228.
41. Pilger A, Rudiger HW (2006) 8-Hydroxy-2'-deoxyguanosine as a marker of oxidative DNA damage related to occupational and environmental exposures. Int Arch Occup Environ Health 480, 1-15.
42. Markesbery WR, Carney JM (1999) Oxidative alterations in Alzheimer's disease. Brain Pathol x9, 133-146.
43. Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem -x68, 2092-2097.
44. Rivera EJ, Goldin A, Fulmer N, Tavares R, Wands JR, de la Monte SM (2005) Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine. J Alzheimers Dis 8, 247-268.
45. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes? J Alzheimers Dis 7, 63-80.
46. Pylypiw HM, Zubroff JR, Magee PN, Harrington GW (1984) The metabolism of N-nitrosomethylaniline. J Cancer Res Clin Oncol 108, 66-70.
47. Gray JI, Skrypec DJ, Mandagere AK, Booren AM, Pearson AM (1984) Further factors influencing N-nitrosamine formation in bacon. IARC Sci Publ, 301-309.
48. Tricker AR, Perkins MJ, Massey RC, McWeeny DJ (1985) Some nitrosoamino acids in bacon adipose tissue and their contribution to the total N-nitroso compound concentration. Z Lebensm Unters Forsch 180, 379-383.
49. Dietrich M, Block G, Pogoda JM, Buffler P, Hecht S, Preston-Martin S (2005) A review: dietary and endogenously formed N-nitroso compounds and risk of childhood brain tumors. Cancer Causes Control 16, 619-635.
50. McKinney PA (2004) Brain tumours: incidence, survival, and aetiology. J Neurol Neurosurg Psychiatry 75 Suppl 2, ii12-17.
51. Chen H, Ward MH, Tucker KL, Graubard BI, McComb RD, Potischman NA, Weisenburger DD, Heineman EF (2002) Diet and risk of adult glioma in eastern Nebraska, United States. Cancer Causes Control 13, 647-655.
52. Kaplan S, Novikov I, Modan B (1997) Nutritional factors in the etiology of brain tumors: potential role of nitrosamines, fat, and cholesterol. Am J Epidemiol 146, 832-841.
53. IvankovicS, Druckrey H(1968) Carcinogenesisin the progeny after exposure of pregnant animals. Food Cosmet Toxicol 6, 584-585.
54. Druckrey H, Preussmann R, Ivankovic S, Schmahl D (1967) [Organotropic carcinogenic effects of 65 various N-nitroso-compounds on BD rats]. Z Krebsforsch 69, 103-201.
55. Cao L, Xu X, Cao LL, Wang RH, Coumoul X, Kim SS, Deng CX (2007) Absence of full-length Brca1 sensitizes mice to oxidative stress and carcinogen-induced tumorigenesis in the esophagus and forestomach. Carcinogenesis 28, 1401-1407.
56. Iwai S, Murai T, Makino S, Min W, Morimura K, Mori S, Hagihara A, Seki S, Fukushima S (2007) High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 mice. Cancer Lett 246, 115-121.
57. LeRoith D (2008) Insulin-like growth factors and the brain. Endocrinology 149, 5951.
58. Elsner M, Guldbakke B, Tiedge M, Munday R, Lenzen S (2000) Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia 43, 1528-1533.
59. Fang YZ, Yang S, Wu G (2002) Free radicals, antioxidants, and nutrition. Nutrition 18, 872-879.
60. Kang D, Hamasaki N (2005) Alterations of mitochondrial DNA in common diseases and disease states: aging, neurode-generation, heart failure, diabetes, and cancer. Curr Med Chem 12, 429-441.
61. Planel E, Tatebayashi Y, Miyasaka T, Liu L, Wang L, Herman M, Yu WH, Luchsinger JA, Wadzinski B, Duff KE, Takashima A (2007) Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms. J Neurosci 27, 13635-13648.
62. Scanlan RA (1983) Formation and occurrence of nitrosamines in food. Cancer Res 43, 2435s-2440s.
63. Jakszyn P, Agudo A, Berenguer A, Ibanez R, Amiano P, Pera G, Ardanaz E, Barricarte A, Chirlaque MD, Dorronsoro M, Larranaga N, Martinez C, Navarro C, Quiros JR, Sanchez MJ, Tormo MJ, Gonzalez CA (2006) Intake and food sources of nitrites and N-nitrosodimethylamine in Spain. Public Health Nutr 9, 785-791.
64. Jakszyn P, Bingham S, Pera G, Agudo A, Luben R, Welch A, Boeing H, Del Giudice G, Palli D, Saieva C, Krogh V, Sacer-dote C, Tumino R, Panico S, Berglund G, Siman H, Hallmans G, Sanchez MJ, Larranaga N, Barricarte A, Chirlaque MD, Quiros JR, Key TJ, Allen N, Lund E, Carneiro F, Linseisen J, Nagel G, Overvad K, Tjonneland A, Olsen A, Bueno-de-Mesquita HB, Ocke MO, Peeters PH, Numans ME, Clavel-Chapelon F, Trichopoulou A, Fenger C, Stenling R, Ferrari P, Jenab M, Norat T, Riboli E, Gonzalez CA (2006) Endogenous versus exogenous exposure to N-nitroso compounds and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study. Carcinogenesis 27, 1497-1501.
65. Jakszyn P, Gonzalez CA (2006) Nitrosamine and related food intake and gastric and oesophageal cancer risk: a systematic review of the epidemiological evidence. World J Gastroenterol 12, 4296-4303.
66. Scanlan RA, Barbour JF, Hotchkiss JH, Libbey LM (1980) N-nitrosodimethylamine in beer. Food Cosmet Toxicol 18, 27-29.